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Abstract
Activin A receptor, type II-like kinase 1 (also called ALK1), is a serine-threonine kinase predominantly expressed on
endothelial cells surface. Mutations in its ACVRL1 encoding gene (12q11-14) cause type 2 Hereditary Haemorrhagic
Telangiectasia (HHT2), an autosomal dominant multisystem vascular dysplasia. The study of the structural effects of
mutations is crucial to understand their pathogenic mechanism. However, while an X-ray structure of ALK1 intracellular
domain has recently become available (PDB ID: 3MY0), structure determination of ALK1 ectodomain (ALK1EC) has been
elusive so far. We here describe the building of a homology model for ALK1EC, followed by an extensive bioinformatic
analysis, based on a set of 38 methods, of the effect of missense mutations at the sequence and structural level. ALK1EC
potential interaction mode with its ligand BMP9 was then predicted combining modelling and docking data. The calculated
model of the ALK1EC allowed mapping and a preliminary characterization of HHT2 associated mutations. Major structural
changes and loss of stability of the protein were predicted for several mutations, while others were found to interfere
mainly with binding to BMP9 or other interactors, like Endoglin (CD105), whose encoding ENG gene (9q34) mutations are
known to cause type 1 HHT. This study gives a preliminary insight into the potential structure of ALK1EC and into the
structural effects of HHT2 associated mutations, which can be useful to predict the potential effect of each single mutation,
to devise new biological experiments and to interpret the biological significance of new mutations, private mutations, or
non-synonymous polymorphisms.
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Introduction
Activin A receptor, type II-like kinase 1 (also called ALK1,
Uniprot entry P37023, protein family (pfam) 01064 of Activin
types I and II receptor domains), is a serine-threonine kinase
predominantly expressed on endothelial cells surface and it acts as
a type I receptor for the Transforming Growth Factor-b/Bone
Morphogenetic Protein (TGF-b/BMP superfamily of ligands.
TGF-b/BMP signalling is induced when a dimeric ligand binds to
the extracellular domain of two type I and two type II receptors
[1]. This hexameric assembly permits interaction between the
intracellular domains, with the constitutively active intracellular
domain of type II receptor cross-phosphorylating the intracellular
glycine-serine (GS) domain of type I receptor [2]. These receptor
complexes can contain a type III receptor also termed a co-
receptor (betaglycan [3], Endoglin [4] or RGM-a, b, c [5]) that
modulates ligand affinity for its type I and type II receptors [6].
From the structural point of view, type I and type II receptors
share a general fold resembling a class of neurotoxins known as
three-finger toxins and hence called ‘‘three-finger toxin fold’’. This
fold is comprised from b-strands stabilised by disulphide bonds
formed by conserved Cys residues. Three pairs of anti-parallel
b-strands are curved to generate a concave surface. Despite the
common architecture and the cluster of conserved Cys residues,
very little sequence identity and no functional overlap exist
between the two types of receptors.
BMPs consist of a Cys knot characterised by three pairs of
highly conserved disulphide bonds in which one traverses through
a ring formed by the other 2. This fold can be described as a hand
with a concave palm side and two parallel b-sheet forming 4
fingers, with each b-strand being likened to a finger. Finger 2 leads
to a helix ‘‘wrist’’ region. In the dimeric ligand the 4 fingers extend
from the Cys core of the protein like butterfly wings. Binding of
type I receptors occurs near the a-helix on the concave side at the
junction between the two subunits [7], whereas binding to type II
receptors happens on the convex side of the hand near the
‘‘fingertips’’ [8,9].
ALK1 shares with other type I receptors a high degree of similarity
in the GS domain, in the following serine-threonine kinase
subdomains and in the short C-terminal tail [10], but the extracellular
domain shows a peculiar aminoacidic sequence. ALK1 ligand has
been elusive for a long time, but it has been recently demonstrated
that BMP9 binds ALK1 in association with BMPRII or ActRIIA
[11–14], inhibiting endothelial cell proliferation and migration.
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in endothelial cells with an EC50 around 50 pg/ml (2 pM). This is a
much higher affinity than that of other BMPs for their type I
receptors: for example, BMP2 has an apparent Kd of 0.9 nM for
ALK3 and 3.6 nM for ALK6 [14]. This feature suggests that the
structural basis of ALK1 receptor binding might be different from
other BMPs, which is further supported by the fact that, in contrast to
all other type I receptors, ALK1 is missing residue F85, which was
shown to be involved in the hydrophobic interactions between other
BMPs and their type I receptors [15,16]. Mutations in the
components of this complex signalling system have been associated
with diseases. Thus, Hereditary Hemorrhagic Telangiectasia (HHT)
is an autosomal dominant multisystem vascular dysplasia character-
ized by mucocutaneous telangiectases and multiple arteriovenous
malformations (AVMs) mainly in lung, liver and brain. Its HHT1
form is determined by mutations of type III receptor Endoglin
(CD105), a homodimeric membrane glycoprotein coded by ENG
(9q34) (OMIM*131195), while HHT2 depends on mutations of
ALK1 coded by the ACVRL1gene (12q11-14) (OMIM*601284). The
pathological basis of the associated vascular malformations is lack of
intervening capillaries and results in direct connections between
arteries and veins. HHT is a Rare Disease, with an incidence of 1 in
5-8000, likely underestimated. Penetrance is complete after the 4
th
decade of life but a large inter and intra-familial variability in
phenotype is observed. Moreover, a combined phenotype of HHT
and Juvenile Polyposis is recognized as the JPHT syndrome, related
to mutations in MADH4 gene (18q21.1; OMIM*600993), coding for
SMAD4, the common mediator of TGF-b/BMPs signalling,
involved in transcriptional activation of as yet unidentified target
genes [17].
To date, 329 different mutations have been reported for ENG
(HHT1) and 272 for ACVRL1 (HHT2) [18] with an uneven
distribution of these mutation between North America/North
Europe population (higher prevalence of ENG mutations) and
Mediterranean populations (higher frequence of ACVRL1 muta-
tions). Our group reported an unusual distribution of mutations in
Italy, with more than 30% of Patients carrying an ACVRL1
mutation in exon 3, which codes for 98% of the extracellular
domain [19]. An issue which has not yet been completely
elucidated is whether mutated ALK1 is expressed or not. In fact,
missense mutations and short in frame deletions and insertions
often impair propensity of the affected polypeptide to fold to the
functional conformation and/or decrease stability of the functional
conformation [20]. Both effects lead to an increase of the
proportion of mutant polypeptide present in non-functional
conformations that are more susceptible to degradation or
aggregation than the functional conformation [20]. Diseases with
this kind of molecular pathogenesis are described as conformational
diseases, and the interest for their pathogenic mechanism is not only
academic: in fact, protein misfolding and aggregation may be an
ideal therapeutic target for diseases caused by trafficking defects of
misfolded secreted proteins. Recently, three mutants of ALK1EC
have been investigated and, though they barely reach the cell
surface and do not bind BMP9, they are expressed in transfected
cells [21], suggesting that alteration of structure determined by
these mutations is likely responsible of the permanence of the
protein in the cell and of the related pathogenic phenotype.
As reported in [22], several recent studies have applied one or a
few bioinformatic methods to predict potentially deleterious effects
of missense mutations in other diseases. However, the emerging
trend is to utilise a more extensive set of prediction methods in
order to attain more reliable results [22]. Many of them are based
on protein sequence, but several are structure-based, as the latter
are more reliable and provide more information. A model of the so
far elusive three-dimensional structure of ALK1EC could therefore
provide insight into its molecular functions and be used to study
the effect of disease-related mutations, like in [23–25]. In this
work, we have built a homology model of ALK1EC applying the
most updated available methods, and we have investigated the
predicted effects of HHT2-related missense mutations of ALK1EC
using multiple computational methods, including docking to the
X-ray structure of BMP9. This approach allowed a preliminary
characterization of ALK1EC mutations, with prediction of their
potential molecular pathogenic effect.
Results and Discussion
In order to tackle mutation analysis by structure-based methods,
we produced a homology model of ALK1EC. The first step
involved identification of the three dimensional fold.
Identification of the three dimensional fold
To create a model of ALK1EC, a BLAST search towards the
PDB database was performed using residues 22–118 of ALK1EC
target sequence (Uniprot entry P37023). No significant similarities
to other known structures were identified (minimum E value=14).
In contrast, a C-BLAST in the Conserved Domain Database
found significant matches within protein family pfam01064, a
domain class characterised by conservation of the CCX(4–5)CN
motif. Though this observation and the absolute conservation of
ten Cys residues throughout the type I receptors of the TGF-b
superfamily [10] suggest a common fold for all its members, Cys-
rich proteins are known to potentially generate alternative folding
patterns, which would influence the choice of the correct template
for homology modelling. In cases where template identification by
sequence alignment fails or is uncertain, ab initio modelling
methods are a possibility, but they are not yet performing
sufficiently well according to the most recent 9th Community
Wide Experiment on the Critical Assessment of Techniques for
Protein Structure Prediction (CASP9, [26]). An alternative is
identification of the correct three dimensional fold by threading
methods, which allows assessment of the compatibility of the target
sequence with the available protein folds based not only on
sequence similarity, but also on structural considerations [27,28].
In order to analyse this problem, ALK1EC was submitted to the
protein fold recognition metaserver Pcons [29–31], which submits
the query sequence to multiple servers at the same time. All fold
recognition servers found templates, with a similar, low sequence
identity (21–23%). Particularly, FORTE, FUGUE, LFUGUE,
LSP3 and SAM-T02 reported BMP receptor IA (PDB entries:
2h62C, 1es7B and 1rewC) as the best template, HHPRED2,
LHHSEARCH15, LPROSPECT2, NFOLD and RPSBLAST
reported BMP receptor IB (PDB entry: 3evsC), and LPPA-I and
MUSTER, reported BMP receptor IA variant IA/IB (PDB entry:
2qjbD) as the best template. Only LSPARKS2 reported TGF-beta
type 2 receptor (PDB entry: 2pjyC) as the best template and
PHYRE the Urokinase plasminogen activator surface receptor,
UPAR (PDB entry: 1ywhC). All of them are members of the
‘‘snake toxin-like’’ superfamily, ‘‘extracellular domain of cell
surface receptors’’ family, according to SCOP database, and
share the same fold. On the basis of these results, we can conclude
that, despite the low sequence identity, comparative modelling can
be considered an appropriate approach to predict the three-
dimensional (3D) structure of ALK1EC.
Prediction of an atomic model for ALK1EC
Availability of experimental 3D templates allowed us to create a
3D model of ALK1EC by homology modelling, taking into account
Modelling Missense Mutations of ALK1 Ectodomain
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26431the difficulties encountered with low sequence identity (between 20
and 40%), a borderline case which has to be treated carefully [32–
34]. Nevertheless, when proteins used for alignment and modelling
belong to the same protein family in which the structure is well
conserved, overall structural similarity can overcome the problem
of low sequence identity [32]. Furthermore, model quality
assessment and comparison of homology models generated by
different algorithms is useful in order to identify problematic
regions. In order to do this, top scoring models were selected
among those obtained by each of the two metaservers Pcons [29–
31] and Genesilico [35], the latter including modelling by multiple
sequence alignment by the Frankenstein Monster approach [36],
and I-Tasser [37] and RaptorX [38], the two servers giving the
best homology modelling results for automated prediction of
human targets using multiple-template threading in CASP9
[26,39].
Pcons metaserver top scoring model (Pcons score: 0.352) was
the one based on the single target-template alignment obtained by
LPPA-I fold recognition server using structure 2qjbD as a template
(Fig. 1A) and was better than those generated by multiple sequence
alignments by the same metaserver, as evaluated by PconsM (data
not shown). Sequence alignments used by I-Tasser, RaptorX and
Genesilico are shown in Fig. 1B, 1C and 1D, respectively. Global
Qmean scores of each generated models ranged from 0.36 (I-
Tasser) through 0.49 (Pcons) and 0.56 (RaptorX) to 0.57
(Genesilico), indicating a significant variability of model quality.
However, superposition of the four models demonstrated that they
shared a virtually identical general fold, with a maximum RMSD
of 1.96 A ˚ between Ca traces of Pcons and I-Tasser generated
models. Analysis of Qmean local scores for each model by
superposition of Qmean server-generated PDB files (Fig. S1A)
indicated that in all the models strands b1, b2 and b3 were
consistently reliable. b4 and b5 strands had slightly higher local
scores, which became even higher in the remaining part of the
polypeptide, especially loops. As a comparison, however, local
Qmean scores for structures available in the same protein family,
like 2h62C and 3evsC, were only slightly higher than those of the
generated ALK1EC models. This supported the fact that the four
models had a significant reliability. In order to further improve the
results and obtain a single final model, MODELLER was used
[40], using the four server-generated models as templates. In this
step, a a helix for residues 70–76, a secondary structure element
recognised by PSIPRED [41] and not present in the starting
structures, was also imposed. The resulting model was then
evaluated by Qmean and showed a significant increase in the
global Qmean score (0.603, Fig S1B). As a further assessment of
Figure 1. Structural alignments. Sequence alignment obtained using ALK1EC by different structure prediction software types: (A) Pcons
metaserver, (B) I-Tasser, (C) RaptorX, (D) Genesilico metaserver. In the alignment in (B) secondary structure elements are indicated. Disulphide bonds
are numbered within circles. Number 2 is in a dashed circle to indicate that it would be destabilising in our ALK1EC model. ALK1EC: ALK1 ectodomain
sequence. Other sequence names are given as PDB IDs followed by chain name. 2qjb: Bone Morphogenetic Protein Receptor Type IA (ALK-3), 2pjy:
TGF-b Receptor Type I (ALK-5); 1okg: 3-mercaptopyruvate sulfurtransferase from Leishmania major, 2h7z: irditoxin, 3evs: Bone Morphogenetic Protein
Receptor Type IB (ALK-6), 2qj9: BMP-2 in complex with BMPR-IA variant B1, 3kfd: ternary complex of TGF-b1, 2qja: BMP-2 in complex with BMPR-IA
variant B12, 1rew: complex of bone morphogenetic protein 2 and its type IA receptor, 2goo: BMP-2 bound to BMPR-Ia ectodomain and ActRII
ectodomain, 2h62: Bone Morphogenetic Protein Receptor Type IA (ALK-3), 1bte: extracellular domain of the type II activin receptor, 1nys: Activin A
bound to ActRIIB P41 ectodomain, 2h5f: denmotoxin.
doi:10.1371/journal.pone.0026431.g001
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measured with an all-versus-all comparison through the ProCKSI
server (www.procksi.net), gave an average TM-score of 0.6260.20,
while the same parameter measured for the final model versus its
structural templates was 0.7160.070 (t-test: P=0.33)’’.Fig. 2A
depicts the model of ALK1EC (in red) overlapped on the most
recurrent templates used in the modelling procedure: Bone
Morphogenetic Protein Receptor Type IA (ALK-3, 2qjb, cyan),
TGF-b Receptor Type I (ALK-5, 2pjy, magenta), Bone Morpho-
genetic Protein Receptor Type IB (ALK-6, 3evsc, green); Bone
Morphogenetic Protein Receptor Type IA (ALK-3, 2h62, yellow);
BMP-2 in complex with BMPR-IA variant B1 (2qj9: light green).
Assessment of ALK1EC model by RAMPAGE for stereochemical
quality [42] showed 92.9% of residues in favoured regions, 4.3% of
residuesinallowedregions,and 2.9%residuesindisallowedregions.
The two residues in disallowed regions (S38 and T82) belong to the
Figure 2. ALK1EC model. (A) Cartoon representation of the most recurrent templates superposed onto the final ALK1EC model. Red: final ALK1EC
model; cyan: 2qjbd; magenta: 2pjyc; green: 3evsc; yellow: 2h62c; light green: 2qj9c. (B) Cartoon representation of secondary structure elements of the
final ALK1EC model. The typical three-finger toxin structure is visible. Yellow: b-strands, red: a-helices, green: loops. Disulphide bonds are displayed as
sticks and numbered in circles according to Fig. 1B. Dashed circle indicates a lacking disulphide bond: conserved in the templates, it would introduce
strain in the model. (C) and (D) Surface mapping of HHT2-related mutation sites on ALK1EC model (yellow). Views of the concave (C) and convex (D)
surface are displayed. In red: non-Cys mutational sites, labelled according to residue number. In blue (unlabelled for clarity): Cys residues. Non-Cys
mutational sites are mainly clustered in the lower two-thirds of the molecule. Figures were prepared with Pymol [106].
doi:10.1371/journal.pone.0026431.g002
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psi angles led to a reduction of Qmean score. Model validation was
also performed by ProSA-web [43], which gave a very good Z-score
of -5.45 and showedthat the plot of the local model quality (energies
as a function of amino acid positions) was consistently negative for
all of them, confirming the absence of problematic parts (Table 1)
[44]. VERIFY3D [45], ProQ LG [46], and ProQ MaxSub [46]
scores were not too far or even better than those of the template
crystal structures (Table 1). Threading energy was also comparable
to the template structures.
In general, the results shown in Table 1 and the superposition of
Fig. 2A indicate that, though the final model is not as good as the
crystallographically determined reference structures, as expected
because of the low sequence identity to the templates, it was
anyway sufficiently good to derive some functional inference. The
model was deposited in the Protein Model Database (PMDB) with
code PM0077425.
Model description
The final model included residues 31–107 (Fig. 2B). The general
shape of ALK1EC model is of a cupped left hand, with the thenar
eminence corresponding to a-helix 1, including residues 70–77,
and the thumb to the loop formed by residues 78–84. The core
region of the model exhibits the characteristic three-finger toxin
fold (Fig. 1 and Fig. 2B), with strand b1 including residues V32-
E37, b2 residues T45-G48, b3 residues C51-R57, b4 residues P63-
G68 and b5 residues V85-C90. Strands 1 and 2, and 2 and 3 are
joined by a short loop, while strands 4 and 5 by a long, partially
unstructured loop, including residues N71-V85 and a short a-helix
(N95 and H98). Only four (C34-C51, C46-C69, C90-C95) of the
expected five disulphide bonds were predicted: none of the four
templates used in the Modeller modelling step included the bond
one between C36 and C41, which is instead present in the crystal
structures of all the other molecules of the same class. This might
depend on the fact that the loop formed by residues E37-H40
includes 4 residues, among which a Pro. All the other members of
the family have 3 or 5 residues loops and do not include Pro.
These two specific elements (unique loop length and Pro presence)
could explain why forcing Modeller to include a disulphide bond
in the final model lead to a worsening of the Qmean score,
especially because of alteration of torsion angles. This disulphide
bond, therefore, was not included in the final model.
Mutation analysis
In general, models with low sequence identity to the template
like the one of ALK1EC cannot be used for detailed predictions
of the effects of mutations. Nevertheless, thanks to the low
deviation of the Ca atoms positions with respect to templates, the
results of our analysis can be used to put forward new hypotheses
and may be helpful in guiding the design of further experimental
research.
At the moment of writing, 32 HHT2-related positions for
missense mutations have been described for ALK1EC (HHT
mutation database, [18]). Mutational sites P26, P30 and S110
were not included in our systematic bioinformatic analysis, as these
residues are not part of our structural model.
Mutation positions are underlined in Fig. 3A and were mapped
on the calculated model of ALK1EC domain in Fig. 2C and
Fig. 2D, where mutational sites not involving and involving Cys
residues are highlighted in red and blue, respectively. A visual
analysis of the mutation positions allowed to observe that they are
located in only two-thirds of the domain body, with the tip of the
fingers completely untouched. They involve residues located both
on the concave and convex surface and the wrist of the hand,
affecting all Cys and some non-Cys residues. In order to better
characterize the mutations, an extensive bioinformatic analysis
was performed, according to Thusberg and Vihinen [22], with
modifications described in the Material and Methods section.
Results are summarised in Table 2 and Fig. 4, and discussed
below.
Sequence conservation. Pathogenic mutations typically
involve conserved positions within a protein family, as these
involve residues essential for the structure and/or the function of a
protein [22,47–49]. In fact, the probability that a random
mutation can cause a genetic disease has been shown to increase
with an increase in the degree of site conservation [50]. The nature
of amino acid substitutions in invariant sites will condition the
effect on protein structure, while variable positions can be analysed
for residues that can be exchanged without detrimental effects.
Pfam [51] multiple sequence alignment for ALK1EC confirms that
there are 11 invariant positions (the 10 Cys and N96), all of which
modified by one or several disease-related mutations. Fig. 3B
shows the chemical nature of amino acids in MultiDisp output
[52], with asterisks above mutated positions: red for absolutetly
conserved positions and black asterisks above the others. Several
missense mutations involving the 10 absolutely conserved cysteine
residues have been identified so far: C34Y, C36Y, C41R, C46L,
C51Y, C69R, C69Y, C77Y, C77W, C89Y, C90Y, C95R.
Another absolutely conserved position is N96, which is mutated
to D in a disease phenotype. In fact, N96 belongs to the Pfam
characterising motif CCX(4–5)CN. Consurf [53] analysis of all
Pfam multiple sequence alignments recognises all Cys residues as
structurally important, and N96 as a functionally important
residue.
Fifteen mutations significantly alter the physicochemical
properties of wild-type amino acids as predicted by ProCon
[54]. Two hydrophobic residues (V32 and W50) are replaced by
Gly, an amino acid with a conformational role and with much a
smaller size. Three Gly residues (G48, G68 and G70) are changed
Table 1. Quality assessment of representative template structures and of ALK1EC model.
Molecule (PDB ID) Qmean [76] Verify 3D [45] ProQ LG [46] ProQ MaxSub [46]
2h62C 0.73 22.13 2.051 0.306
2qjbD 0.72 24.02 1.072 0.173
3evsC 0.74 25.11 1.370 0.220
2qj9D 0.77 24.90 1.208 0.184
2pjyA 0.71 17.33 1.228 0.209
ALK1EC 0.60 19.90 1.355 0.231
doi:10.1371/journal.pone.0026431.t001
Modelling Missense Mutations of ALK1 Ectodomain
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26431Figure 3. Bioinformatic analysis of HHT2 related ALK1EC missense mutations. (A) Comparison of HHT2 related mutations with residues
contacts. Top line: missense mutations are underlined in the sequence of ALK1EC. Red and green: mutations with a higher and lower impact,
respectively, on protein folding according to our bioinformatic analysis (see also Table 2). Pink: residues involved in interactions with BMP9. Triangles
are used to allow visualization of two colours when needed. Bottom line: Sting [64] output for contact analysis. Residue colour legend: grey: small and
hydrophobic; green: polar; red: negatively charged; blue: positively charged; yellow: disulphide forming cysteines. (B) MultiDisp [52] output of the
sequence alignment of ALK1EC with its homologues. The height of the character is proportional to the frequency of the amino acid in that position.
Similar colours are used for residues with similar physicochemical properties. Red asterisks indicate absolutely conserved residues, black ones other
mutational residues. (C) Covarying residues determined with the program ProCon (p-value 0.001). Mutational sites are highlighted pink. Figures were
prepared with Pymol [106].
doi:10.1371/journal.pone.0026431.g003
Modelling Missense Mutations of ALK1 Ectodomain
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26431either into charged residues (Glu or Arg) or into a hydrophobic
Cys. The former mutation might not be, however, very disruptive,
as Glu is found in this position in some members of the Pfam
group analysed by all the different alignment algorithms. The
positively charged H66, R67 and H87 are mutated, respectively,
into a conformationally important residue (Pro), which is likely to
interrupt the continuity of the b-strand, into a hydrophobic
residue (Trp) and into an oppositely charged residue (Asp). A Gln
in position 67, on the other hand, might be more easily tolerated,
as it is found in homologues by all MSA generators used. It is
expected, therefore, that mutations G48E and R67Q will lead to a
less disruptive action from the structural point of view.
There are four pairs of covarying residues (Fig. 3C), with 3
amino acids mutated in HHT2. In summary, our analysis shows
that pathogenic mutations are located not only in absolutely
conserved positions, but also in residues with a low level of
evolutionary conservation.
Structural disorder and b-aggregation. Disorder and
aggregation propensity of a protein can be increased by missense
mutations, leading to loss of a regular secondary structure fold.
These mechanisms have been recognised to be involved in
Alzheimer’s [55], Huntington’s diseases [56], amyloidosis [57] and
even aging [58]. At least three of the seven methods used predicted
six mutations as able to increase disorder, and at least two of the
four methods used predicted four of them as potentially able to
influence aggregation.
Stability. The most frequent effect of missense mutations is
alteration of protein folding and decreased stability [20]. Stability
centres were predicted by Scide [59] and Scpred [60] and
stabilizing residues by Sride [61]. Only mutated residue W50 was
found to belong to the first group, while no residues were found to
exert an essential stabilizing effect. However, when these results
were considered together with those obtained with the 8 softwares
used to test changes in stability upon mutations, all amino acid
replacements were predicted to be destabilising by at least 4
methods, or, in the case of mutations C41R, W50G, C51Y, C69R,
C69Y, H87D, C89Y, C95R and N98S , by at least 6 methods.
Structural mutations. Amino acid replacement can
determine major structural alterations, mainly determined by the
physico-chemical properties of the new residue. Analysis of the
fitting of each new side chain was performed using structural
models generated by FoldX, which adopts a probability-based
Table 2. Summary of the effects of ALK1EC mutations.
Mutation
Conserved
residues
Electrostatic
potential Conformational
Contacts and
stability Disorder Aggregation
Functional
mutations
Contacts
with BMP9
V32G -- - - x- -x
C34Y x- x x x- x-
C36Y xx x x x- x-
C41R xx - x x- x-
C46L x- - x x- x-
R47P -x - x x- -x
G48E -x - x x- -x
G48R -x - x x- -x
W50G -- - x x- --
W50C -- - x x- --
C51Y xx x x x- x-
T52A -- - x -- -x
H66P -x - x -- -x
R67W -x - x -- -x
R67Q -- - x x- -x
G68C -- - - -- -x
C69R xx - x x- x-
C69Y x- - x x- x-
G70R -x x x -- -x
C77W x- - x -- x-
C77Y x- - x x- x-
G79R -x - - x- -x
H87D -x - x -x -x
Y88C -- - x -- --
C89Y x- - x -x x-
C90Y x- x x xx x-
C95R xx x x x- x-
N96D x- x x -- x-
N98S -x - x -x x-
doi:10.1371/journal.pone.0026431.t002
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surrounding side chains. For each mutant, van der Waals clashes
were compared with the corresponding wild-type structures using
the corresponding energy values. Wild-type ALK1EC had a van
der Waals energy of –0.06 kcal/mole, while 12 out of the 28
mutants analysed showed higher values, comprised between
1.8 kcal/mole for C89Y and 26.14 kcal/mole for C51Y,
indicating a strong local perturbation to the structure. Each
mutant was analysed by Pymol and clashes visualised by a specific
python function written by Thomas Holder (show_bumps.py,
personal communication). Seven of the 12 mutants with high
energy showed a clear bad fitting, with potential detrimental
effects on folding (Table 1, ‘‘Conformational’’ column). A
representative case of these mutations is illustrated in Fig. 5A.
Mutations introducing proline residues, like R47P and H66P
are located at the base and in the concave surface of the ‘‘hand’’,
respectively. The former is likely to determine a change in the
conformation of the b-strand including residues 45–48, while the
latter affects one of the two symmetric His residues (H66 and H87)
located in the middle of b-strand 2.
Mutations in contacts maintaining stability. Accessible
surface area measurements performed by Areaimol [62,63]
indicate that ALK1EC includes, despite its small size and its
mainly b secondary structure, ten completely buried residues. Out
of these, nine are mutational sites (C34, C36, C46, C51, T52,
G68, G70, C95, N96), which is consistent with the notion that
buried residues are typically involved in the formation of core
interactions crucial for protein stability and that the probability of
a mutation to be pathogenic is inversely proportional to the solvent
accessible surface of the wild-type residue [50].
Residues T52, R67, Y88, C95 and N96 form a high number of
bonds with neighbouring aminoacids, as displayed by Sting
analysis [64] (Fig. 3A). All the mutations involving these residues
involve a reorganization of the bond network, and could thus
contribute to alteration of protein stability. However, it must be
taken into account that, when interactions in the wild-type protein
are mediated by main chain – main chain contacts, they are less
susceptible to be broken by missense mutations. This happens, for
example, in Y88C.
Mutations affecting Cys involved in highly conserved disulphide
bonds are known to strongly alter protein stability and folding.
This is consistent with the results of our bioinformatic analysis
(Table 2) and with biological data reported by Ricard et al. [21]. A
specific feature of the Pfam family ALK1 belongs to is the presence
of the CCX(4–5)CN motif, with C89, C90, C95 and N96 the
corresponding residues involved in ALK1EC, respectively. Their
crucial structural role depends on the fact that, in all the members
of the Pfam protein family whose structures are known, the first
Cys residue of the motif (C89) forms a disulphide bond with the
Cys comprised in the a1 helix (C77 in ALK1EC), while the second
Cys residue (C90) forms a disulphide bond with the third Cys of
the motif (C95), thus placing the following Asn residue (N96) in a
favourable position to interact with the N terminal b1 strand of the
domain (Fig. 5B). N96 is thus the pivotal residue around which the
entire structure is folded. Ideally, its ND2 atom is at the centre of a
triangular structure, wherefrom three bonds depart. One is the
covalent bond with the CG atom of the same residue, and the
other two the hydrogen bonds formed with T35 and T52, sewing
the N terminal b1-strand with the b3 (middle finger) and the C
terminal strands, with the latter generating the convex surface of
the ectodomain (Fig. 5C). In the N96D mutant (Fig. 5D) all these
bonds are lost, with a likely alteration of protein fold and of the
proper orientation of sugars potentially linked to N98. Biological
data supporting the results of our analysis are given in [21], where
mutations C51Y, C77W and N96D have been studied into details,
and demonstrated to allow expression of the corresponding
mutated protein, though imparing its exposure on the cell surface.
No measurements concerning folding status of mutant proteins or
subcellular localization was performed in this work. However, the
fact that mutants are detectable in western blot [21] suggests that
they cannot reach the cell surface despite correct protein synthesis.
In fact, misfolding in mutated proteins has been described as a
major cause of impaired surface expression for the neural cell
adhesion molecule L1 [65], with other examples represented by
the cystic fibrosis transmembrane conductance regulator (CFTR)
mutants [66,67], most forms of a1-anti-trypsin deficiency [68], or
Charcot-Marie-Tooth disease caused by missense mutations in the
connexin-32 gene [69] (a review is in [20]). In all these cases, the
Figure 4. Graphical representation of the effects of mutations. The chart summarizes the effect of mutations on ALK1EC protein structure.
Red and green bars: mutations with a high and low, respectively, destabilizing effects on protein structure.
doi:10.1371/journal.pone.0026431.g004
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hence, retained in the endoplasmic reticulum where it is degraded
by the ‘‘quality control’’ machinery. Correct folding and
oligomerization of newly synthesized membrane and secretory
proteins are prerequisites for export from the endoplasmic
reticulum. Mutant and misfolded polypeptides or unassembled
subunits of oligomeric proteins are retained in this organelle and
ultimately degraded (reviewed in [70]). The mechanism by which
mutants are recognised and disposed of by this apparatus are not
well understood. In vitro folding studies would be useful in this
respect for ALK1EC, as several mutations might interfere with
correct folding of the polypeptide and decrease its stability [71].
Since only main chain atoms of the two residues hydrogen
bonded to N96 are involved in structure stabilization, their
mutations would be considered unlikely to determine strong fold
alterations. T35 is not a mutational site. On the other hand,
mutation T52A in the mutated FoldX-generated model alters the
bond network involving N96 in a way totally similar to mutation
Figure 5. Structural effect of mutations. (A) Mutation C51Y causes major clashes with neighbouring residues. (B) Structural role of the highly
conserved CCX(4-5)CN motif. The central b-strands is connected with a1-helix by disulphide bond C77-C89 and with a2-helix by disulphide bond C90-
C95 combined with the hydrogen bonds formed by the N side chain atom of N96. Mutations affecting this motif have a high structural impact. (C)
N96D mutation removes the N96 side chain N atom and its replacement by the C atom of D96 alters the hydrogen bond network. (D) and (E) show
the effect of mutation H87D on electrostatic surface potential (from neutral to negative).
doi:10.1371/journal.pone.0026431.g005
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through its side chain OH, useful to optimize the orientation of the
a1 helix against the concave surface of the hand. In this case,
replacement of the side chain of T52 with an Ala would lead to
loss of this potential interaction. Alternatively, T52 might also be
involved in ligand binding, a hypothesis that we tested by docking
simulation (see below).
R67, beyond binding E65 on the same b-strand, establishes
hydrogen bonds with E37 from the N-terminal strand and with
H97 from the helix of the convex surface. Therefore, it might have
a role complementary to N96. Replacement of R67 by Trp
disrupts these bonds, potentially jeopardizing the stability of the
convex surface of ALK1EC.
Effects on electrostatic potential. Fourteen out of the 29
known ALK1EC mutations determine alterations in the
electrostatic potential: a hydrophobic to negative shift is caused
by mutation G48E and H87D (Fig. 5E), and the reverse by
mutations C36Y and H66P. A positive to hydrophobic shift is
introduced by mutation R47P, while an increase in the negative
surface extent is determined by C51Y and R67W. The most
frequent alteration consists in the hydrophobic to positive shift
induced by mutations C41R, G48R, C69R, G79R, and C95R.
Interestingly, G48E and G48R induce an important alteration of
surface charge distribution, introducing a large negative and
positive patch, respectively, on a hydrophobic area of the convex
surface of ALK1EC. All these alterations might have an effect on
the interactions with BMP9, endoglin, and other potential ligands,
but it is worthwhile noting that also surface charges are relevant in
maintaining protein stability.
Surface mutations. According to our model, non-Cys
mutations involve both the concave and the convex surfaces of
ALK1EC. Particularly, mutational sites R47, T52, H66, R67, G68,
G70, G79, H87 are located on the former. Of these, H66 and H87
are symmetrically located at the sides of a vertical hydrophobic
groove whose floor is formed by residues V53, V54, L55, V56,
F84. Five of the mutated non-Cys positions, occupied mainly by
hydrophobic residues in the wild-type (V32, G48, A49, W50, G70,
Y88), cluster instead on the convex surface of ALK1EC suggesting
that they might be located in a critical region for protein-protein
interactions. In fact, changes introduced by the described missense
mutations determine important alterations in size and charge
(V32G, G48R, G48E, W50G, W50C, G70R, Y88C, C89Y),
which would significantly alter the conformation of this surface
region.
Functional mutations. ALK1EC conserved residues have
also a functional role, related to their being essential for a correct
protein folding. Thus, all mutations affecting Cys residues and
residues N96 and N98 belong to this class.
Pathogenic mutations. All the ALK1EC mutations
described here are known to be pathogenic. SIFT predicted all
of them to be potentially damaging except for Y88C. Pmut
predicted only T52A and N96D as tolerated instead of deleterious.
Polyphen and PhDSNP considered 6 and 13 mutations,
respectively, as tolerated.
Subsets of mutations. A summary of the data presented in
Table 1 is illustrated in Fig. 4, where bars represent the score (total
number of crosses) obtained in our analysis by each mutation. The
chart suggested that it might be possible to hypothesise a
preliminary classification of ALK1EC missense mutations:
mutations probably leading to protein misfolding and
impairment of ALK1 surface expression by protein aggregation
or by lack of binding of key components of the secretory pathway
(Table 1 and on the left in Fig. 4), and non-destabilizing mutations,
which might allow a significant or normal cell surface expression of
ALK1, mainly exerting their pathogenic effect by interference with
BMP9 or co-receptor binding (Table 1 and on the right in Fig. 4).
Discrimination between the two classes by a clear-cut threshold
was however difficult at this stage. We then decided to test our
model in a docking simulation to determine which mutational
residues would be expected to reside in interacting surfaces.
Prediction of the interaction mode of ALK1EC with BMP9
We performed a docking simulation with ClusPro 2.0 [72]
between ALK1EC and the structure of the dimeric form of BMP9
[PDB: 1ZKZ]. Though to be considered with great caution for the
errors intrinsic to the ALK1EC model used, the top scoring model
of the complex (Protein Model Database code PM0077426)
suggests a binding mode strikingly similar to the one between
BMP2 (31% identity to BMP9, Fig. 6A) and BMPR-IA complex
(PDB ID: 1es7, Fig. 6B). Interaction with BMP9 occurs at the
composite interface formed by the two ligand monomers, exactly
the same kind of binding strategy displayed by other receptors of
the same class (e.g. PDB IDs: 1es7, 2h62; Fig. 6B). This result can
be considered an important, indirect confirmation of the reliability
of our ALK1EC model. Moreover, in the complex with BMP9
ALK1EC is oriented with a rotation by 90u with respect to BMPR-
IA (Fig. 6B). This is in line with the view that, in these families of
molecules, variable structural strategies for complex formation
provide the specificity of interaction and hence of final signalling
cascade. BMP9 residues involved in binding have a striking
similarity with those recruited at the interface in the BMP2-
BMPR-IA complex (PDB ID: 1es7, Fig. 6A, pink). Extra-residues
are also involved in the case of ALK1EC-BMP9 interface (Fig. 6A,
pink), indicating a more extensive interaction surface, which could
explain the very high affinity measured in in vitro experiments for
this complex [14].
Some important observations can be made. First of all, in both
complexes ligand-receptor interactions occur mainly through
hydrophobic patches. The concave surface of BMPR-IA is largely
hydrophobic due to residues F60, G76, M78 and I99 and the
disulphide bridge between C77 and C53. It is interesting to note
that none of these residues is conserved in ALK1EC, except for
G76 (G68 in ALK1EC). However, a wide hydrophobic surface
area is present in the central part of the concave surface thanks to
residues V54, V56, F84, V85 and L103 (Fig. 5C). In BMPR-IA,
the hydrophobic concave surface is filled by residues from the pre-
helix loop of BMP2, particularly F49, P50 and A52. A key feature
of BMPR-IA binding is residue F85, which sticks out of the
receptor helix a1 and fits, with a knob-into-hole packing, into a
hydrophobic pocket of the ligand [7]. All of the pocket forming
residues of BMP2 are invariant or highly conserved within the
TGF-b superfamily, including BMP9 [73]. In fact, a highly
hydrophobic residue corresponding to F85 of BMPR-IA is found
in all type I receptors and has been proposed as a key feature of the
type I receptor binding site [7]. However, in ALK1EC the critical
residue F85 is replaced by E75, clearly unfit to bind the
hydrophobic binding pocket. This sequence feature of ALK1EC
suggested per se that binding of BMP9 was likely to occur through
interactions different from those observed in the BMP2/BMPR-IA
complex. In fact, the ca. 90u rotation (Fig. 6B and 6C) perfectly
sorts out this charge problem, moving E75 completely outside the
binding interface.
It is intriguing that the top scoring complex model showed an
interaction interface with BMP9 including 10 out of the 14 non-
Cys missense mutational positions for ALK1EC. They include, for
the interface between ALK1EC and BMP9 monomer A, residue
R47, and for monomer B: V32, R47, G48, T52, H66, R67, G68,
G70, G79 and H87. All these 10 mutational hotspots include
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PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e26431Figure 6. ALK1EC-BMP9 docking simulation. (A) Sequence alignment of BMP2 from PDB structure 1es7 and BMP9 from PDB structure 1zkz.
Sequence numbering according to BMP9. Residues involved in type I receptor binding are shaded in pink. For BMP9, interface residues were
calculated with PISA [108]. (B) Superposition of ALK1EC/BMP9 complex, as calculated by ClusPro onto BMP2/BMPRIA (PDB ID: 1es7) by BMPs structural
alignment. In two shades of blue: surface of BMP9 subunits A and B (BMP2 not shown for clarity). In yellow and magenta: cartoon representation of
BMPRIA and ALK1EC, respectively. (C) BMPRIA and ALK1EC from (B) are visualised from the interface surface. The latter is rotated by about 90u with
respect to the former. Mutational positions of ALK1EC contacting BMP9 are shown as cyan sticks. (C) ALK1EC-BMP9 complex simulation: surface
representation of ALK1EC (magenta) and stick representation of BMP9 segments involved in binding (dark blue: subunit B, light blue: subunit A). Cyan:
non-Cys mutational sites from (C), in contact with BMP9.
doi:10.1371/journal.pone.0026431.g006
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our analysis (Table 2, green bars in Fig. 4, Fig. 6). Two residues,
Y88 and W50, do not seem to affect ALK1EC structure or its
binding to BMP9. For its localization on the convex surface of
ALK1EC, Y88 might be involved in its interactions with another
partner, like, for example, a co-receptor. A similar line of
reasoning can be applied to residue W50, targeted by pathogenic
mutations W50G and W50C, which do not exert a crucial
structural modification role and are not involved in interactions
with the ligand.
The results of this simulation were also a further, indirect
confirmation that the group of mutations represented with red
bars in Fig. 4 affect residues which are more likely to have a
structural role.
Conclusions
HHT2-associated missense mutations detected in ALK1 result
in a clinically relevant phenotype due to receptor functional
impairment. Thus, they offer an invaluable source of information
for protein genotype-phenotype correlation, as they can demon-
strate the importance of wild-type residues located in mutational
spots in determining the correct molecular conformation and/or
in mediating interactions at the ligand-receptor interface. The
rationale of our work relies on the fact that the study of the
molecular basis of diseases by experimental methods is difficult
and time-consuming, and prediction of the structural effects of
pathogenic mutations may optimise the design, and reduce the
number, of targeted biological experiments. The multiple
combined bioinformatic methods, which we have applied to
HHT2-related ALK1EC pathogenic mutations required genera-
tion of a three-dimensional homology model of ALK1EC, the first
good-quality model of ALK1 receptor ectodomain proposed so
far. Consistency between independent predictions, particularly of
HHT2 related missense mutation effects and docking simulation,
is quite striking and suggests that a preliminary classification of the
29 ALK1EC missense mutations here analysed would include three
groups, affecting: residues mainly involved in protein structure
stabilization (14 out of 29), residues mainly involved in interaction
with BMP9 (12 out of 29), and, finally, residues likely to be
involved in interactions with other partners, probably coreceptors
(3 out of 29). These data lead to hypothesise that the similar
clinical phenotypes of HHT2 might actually depend on alteration
of at least three different molecular pathways or mechanisms:
protein misfolding (thus configuring a conformational disease),
ligand binding disruption or interference with co-receptor binding.
It is important to consider that each bioinformatic method
investigates a specific aspect of the sequence or structure under
consideration and implementing a considerable number of
methods is a common strategy to integrate their strengths and
overcome their weaknesses. Metaservers apply this philosophy on
a wide scale for homology modelling and integrate statistical
methods to assess the results. As a maximum number of methods is
tested per each query sequence, integration of a system to
automatically assess the results from different metaservers could be
very useful to speed up and improve homology modelling. Protein
threading itself is being the object of much improvement effort,
especially to optimize alignments and energy functions [74], while
assessments methods could be improved in order to better identify
regions that can be trusted, with unreliable parts piped
automatically to systems to improve them.
In the bioinformatic determination of pathogenic mutations,
several different principles are at the base of the available methods,
which is the reason why different results can be obtained for the
same query. A single query system is under development (http://
bioinfo.uta.fi/PON-P) and a method to assess and integrate the
results would be welcome as well, as careful choice and
understanding of the methods and their limitations is still
important to avoid overprediction. At the moment, as these
methods cannot find a clear correlation with a disease phenotype,
specifically designed experiments are still required.
Because of all these limitations, it would be risky to consider our
findings conclusive. In contrast, we believe that they can give an
initial but solid structural interpretation of how mutational
alterations of ALK1EC can lead to HHT2, and hence a valuable
framework to systematically tackle the molecular basis of its
pathogenesis by biological methods.
Materials and Methods
Comparative protein structure modelling
The amino acid sequence of human ALK1EC (residues 22–118)
was taken from Uniprot entry P37023. Pcons metaserver [29–31]
was used for identification of the three-dimensional fold. Four
initial models were generated by Pcons [29–31], Genesilico [35], I-
Tasser [37] and RaptorX [38], respectively. A fifth and final
model was then obtained by running Modeller [75] using these
four models as templates and secondary structure elements
predicted by PSIPRED [41]. Models and structures were assessed
by the Qmean server [76], the best performing and publicly
available model quality assessment software in CASP9 [26], and
by RAMPAGE [42], ProSA-web [43], VERIFY3D [45], ProQ
[46].
Missense mutation analysis
Twenty-nine missense mutations located in ALK1EC, both
deposited in the HHT database [18] and/or described by our
group [19], were analysed. All modelled mutations were therefore
found in HHT patients diagnosed as surely affected as reported by
Shovlin et al. [77]. The method of Thusberg and Vihinen [22] was
applied to study the effect of mutations, with the modifications and
implementations described below. A total of 27 sequence
homologues for ALK1EC domain and sequence alignments were
from the Pfam database [51]. Alignments were calculated with
Mcoffee [78], MAFFT [79], Promals [80], Clustalw [81] and
Muscle [82], and visualized using MultiDisp [52] and ConSeq
[53] for illustration of conserved amino acids in the sequence. The
default parameters were applied in all methods.
The evolutionary conservation of the sequences was studied, in
addition to the visualization programs, by ProCon, a program for
calculating mutual information and entropy in amino acid
sequences [54]. Conservation indices were calculated with the
ConSurf server [53].
Structural disorder in the protein and the effects of mutations
were studied using seven methods, Disopred [83], IUPred [84],
PrDOS [85] Ronn [86], Pondr [87], Poodle-S [88], Spritz [89].
The effects of mutations on aggregation propensities were studied
by TANGO [90], PASTA [91], Waltz [92], AGGRESCAN [93].
The pathogenic effects of point mutations were analyzed using
SIFT [94], PolyPhen [95], Pmut [96], and PhD-SNP [97]. The
effects of mutations on protein stability were predicted by Scpred
[60], Scide [59], Sride [61], PoPMuSiC [98], FoldX [99],
Dmutant [100], Cupsat [101], Imutant [102], Mupro [103],
Iptree-STAB [104] and Eris [105]. Instead of modelling the
mutations manually as described by Thusberg and Vihinen [22],
the BuildModel option of FoldX version 3.0 beta, whose force field
is detailed in [99], was used. The BuildModel command reads the
PDB and duplicates it internally. Then, it mutates the selected
position in one molecule to itself and, in the other, to the variant
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side chains and the rotamer set for them are the same in both
cases, such that artefactual changes in energy due to the release,
for example, of a clash in a neighbouring side chain in the mutant
are prevented. The effect of the mutation is then computed by
subtracting the energy of the self-mutated wild-type from that of
the mutant, obtaining DDG values that are provided in kilocalories
per mole of ALK1EC [99].
Amino acid contact analysis was performed with Sting [64] and
PyMol [106]. By analyzing the wild-type protein, we could
determine structurally important amino acids, which contribute to
the stability of the protein, or amino acids with strong contacts that
may be important for functional specificity. The analysis of
changes in the contact energies for mutant structures provided
hypotheses for the roles of the mutated amino acids. Electrostatic
surface potentials were calculated and visualised with the PyMOL
program [106] using the absolute electrostatic potential in a
vacuum. Accessible surface area was calculated with Areimol [63].
Docking
Docking analysis was performed by ClusPro [72]. In this
software, a rigid body docking is performed, using ZDOCK [107]
based on the fast Fourier transform correlation techniques.
ZDOCK uses a scoring function based on shape complementar-
ities, electrostatic potentials, and desolvation terms. Second,
filtering is performed using empirical free energy functions and
pairwise root mean square deviation clustering. The ligand with
the most neighbours is the cluster center, which is then minimized
by the CHARMM algorithm in the presence of the receptor. For
ALK1EC, the homology model we generated was used, and, for
BMP9 structure, the dimeric form of BMP9 (PDB ID: 1zkz) was
docked.
Visualisation of models and interface analysis
Visual inspection of the models and structures, and preparation
of the figures was carried out using the program Pymol [106].
Interface analysis was performed with PISA [108].
Supporting Information
Figure S1 Local Qmean scores of ALK1EC models.
Cartoon representation of (A) superposed ALK1EC models
generated by Pcons [29-31], Genesilico [35], I-Tasser [37] and
RaptorX [38], (B) final model generated by MODELLER [40].
Molecules were coloured with a blue (low Qmean score) to red
(high Qmean score) gradient.
(TIF)
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